Skip to main content

Inside the market strategies of today's drugmakers

Patent protection will run out later this decade for many multibillion-dollar medicines and will force their large pharmaceutical makers to find new products and markets. Explore some of the most important trends shaping the largest drugmakers’ market strategies in this Trendline.

included in this trendline
  • Higher sales, obesity drug potential fuel Lilly stock rise
  • Novo hikes sales outlook on rising potential for obesity, diabetes drugs
  • FDA approval opens door to wider use of Alzheimer’s drugs
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.